Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
301509 Kingchem
- 31.48
- +5.25+20.02%
Market Closed Apr 24 15:00 CST
3.79BMarket Cap54.75P/E (TTM)
31.48High30.07Low132.96KlotVolume30.27Open26.23Pre Close413.48MTurnover23.43%Turnover Ratio98.07P/E (Static)120.45MShares42.6852wk High1.73P/B1.79BFloat Cap22.1052wk Low31.48Limit Up56.74MShs Float78.71Historical High20.98Limit Down5.38%Amplitude22.10Historical Low0.57Dividend TTM31.10Avg Price71.58KlotAsk1.81%Div YieldTTM100Lot Size53.46KlotBid
Kingchem Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 41.83%176.34M | -35.19%497.01M | -33.93%387.2M | -39.36%261.99M | -41.87%124.33M | 7.00%766.82M | 3.39%586.07M | 15.24%432.03M | 38.48%213.89M | 30.50%716.67M |
| Operating revenue | 41.83%176.34M | -35.19%497.01M | -33.93%387.2M | -39.36%261.99M | -41.87%124.33M | 7.00%766.82M | 3.39%586.07M | 15.24%432.03M | 38.48%213.89M | 30.50%716.67M |
| Other operating revenue | ---- | 89.50%225.5K | ---- | -15.73%53.08K | ---- | -73.63%119K | ---- | -37.67%62.99K | ---- | -77.94%451.28K |
| Total operating cost | 13.14%125.4M | -16.78%463.3M | -14.65%358.29M | -23.21%232.39M | -32.47%110.84M | 6.05%556.74M | 9.56%419.79M | 17.78%302.63M | 41.67%164.13M | 15.85%524.98M |
| Operating cost | 14.46%86.25M | -20.50%321.87M | -21.63%235.75M | -33.10%152.68M | -39.37%75.35M | 1.07%404.85M | -2.15%300.8M | 13.15%228.21M | 51.34%124.29M | 21.87%400.57M |
| Operating tax surcharges | -13.41%1.59M | 0.77%6.17M | 10.34%5.1M | 9.75%3.23M | 34.31%1.84M | 14.08%6.12M | 34.73%4.62M | 40.67%2.95M | 37.75%1.37M | 32.20%5.37M |
| Operating expense | -3.81%4.9M | -17.63%20.98M | 5.60%22.96M | 7.39%14.58M | -14.90%5.09M | 7.76%25.48M | 22.28%21.75M | 27.97%13.58M | 28.65%5.99M | 38.82%23.64M |
| Administration expense | 12.42%27.29M | -5.37%88.51M | -4.68%73.22M | 5.33%49.85M | 18.11%24.28M | 5.39%93.53M | 19.81%76.81M | 16.44%47.32M | -0.92%20.55M | 20.19%88.74M |
| Financial expense | 38.65%-1.65M | -198.27%-9.77M | 9.26%-3.3M | -55.55%-4.89M | -172.10%-2.69M | 83.06%-3.28M | 86.00%-3.64M | 67.09%-3.14M | 144.38%3.73M | -493.73%-19.34M |
| -Interest expense (Financial expense) | -64.81%25.83K | -85.39%321.81K | -94.48%101.89K | -93.85%77.72K | -90.69%73.42K | -46.57%2.2M | 4.06%1.84M | 12.38%1.26M | 46.66%788.86K | 61.53%4.12M |
| -Interest Income (Financial expense) | -72.14%-1.74M | -59.09%-6.18M | -28.72%-3.27M | -72.44%-2.1M | -96.22%-1.01M | -421.73%-3.88M | -357.29%-2.54M | -914.03%-1.22M | -810.87%-514.15K | -36.18%-744.42K |
| Research and development | 0.77%7.02M | 18.29%35.53M | 26.31%24.55M | 23.59%16.93M | -15.04%6.96M | 15.56%30.04M | 18.48%19.44M | 19.76%13.7M | 41.12%8.2M | 5.55%25.99M |
| Credit Impairment Loss | -114.46%-541.01K | 477.97%2.68M | 159.03%2.23M | 67.29%-1.82M | 881.93%3.74M | -243.97%-709.29K | -467.08%-3.77M | -239.89%-5.57M | -149.21%-478.38K | 157.13%492.66K |
| Asset Impairment Loss | ---- | -74.39%-22.23M | -280.64%-2.44M | -280.64%-2.44M | ---- | -67.99%-12.75M | 131.80%1.35M | 140.33%1.35M | 2.96%-1.3M | -8.23%-7.59M |
| Other net revenue | -18.70%5.34M | 178.68%5.01M | 3,173.96%17.07M | 268.63%4.72M | 974.72%6.57M | -394.24%-6.37M | -88.91%521.51K | -192.47%-2.8M | -293.19%-751.59K | -36.01%2.17M |
| Fair value change income | --699.03K | --455.86K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Invest income | 111.52%3.38M | 299.92%19.01M | 664.43%13.11M | 487.37%7.19M | 185.93%1.6M | 1,406.92%4.75M | 734.85%1.71M | --1.22M | --558.42K | -791.46%-363.66K |
| Asset deal income | ---- | -24.62%-612.88K | ---- | ---- | ---- | ---491.79K | ---- | ---- | ---- | --0 |
| Other revenue | 46.28%1.81M | 102.44%5.72M | 241.46%4.18M | 810.26%1.8M | 165.28%1.24M | -70.66%2.82M | -85.06%1.22M | -97.54%197.44K | -38.20%466.3K | -14.62%9.63M |
| Operating profit | 180.49%56.28M | -80.99%38.73M | -72.43%45.98M | -72.89%34.32M | -59.06%20.07M | 5.08%203.71M | -11.46%166.8M | 4.65%126.61M | 25.71%49.01M | 95.00%193.86M |
| Add:Non operating Income | --0 | 1,064.93%661.24K | 1,530.31%715.26K | -58.72%238.08K | -72.23%10.55K | -63.18%56.76K | -69.61%43.87K | 314.07%576.71K | -48.89%37.97K | -87.99%154.18K |
| Less:Non operating expense | 257.95%22.4K | -65.41%125.54K | -1.25%366.73K | -20.54%294.51K | -86.35%6.26K | 47.27%362.91K | 52.38%371.38K | 578.76%370.64K | 498.70%45.86K | -71.28%246.42K |
| Total profit | 180.31%56.26M | -80.70%39.26M | -72.17%46.33M | -72.98%34.26M | -59.04%20.07M | 4.97%203.41M | -11.58%166.47M | 4.75%126.81M | 25.47%49M | 94.08%193.77M |
| Less:Income tax cost | 165.60%8.84M | -97.80%655.28K | -65.27%7.04M | -85.45%2.17M | -60.05%3.33M | -7.69%29.83M | -38.86%20.27M | -29.67%14.92M | 42.58%8.34M | 111.33%32.32M |
| Net profit | 183.24%47.42M | -77.76%38.61M | -73.13%39.29M | -71.32%32.09M | -58.83%16.74M | 7.51%173.57M | -5.75%146.21M | 12.06%111.89M | 22.46%40.67M | 90.96%161.45M |
| Net profit from continuing operation | 183.24%47.42M | -77.76%38.61M | -73.13%39.29M | -71.32%32.09M | -58.83%16.74M | 7.51%173.57M | -5.75%146.21M | 12.06%111.89M | 22.46%40.67M | 90.96%161.45M |
| Net profit of parent company owners | 183.24%47.42M | -77.76%38.61M | -73.13%39.29M | -71.32%32.09M | -58.83%16.74M | 7.51%173.57M | -5.75%146.21M | 12.06%111.89M | 22.46%40.67M | 90.96%161.45M |
| Earning per share | ||||||||||
| Basic earning per share | 105.26%0.39 | -81.50%0.32 | -78.85%0.33 | -78.23%0.27 | -69.84%0.19 | -30.80%1.73 | -35.00%1.56 | -20.00%1.24 | 23.53%0.63 | 89.39%2.5 |
| Diluted earning per share | 105.26%0.39 | -81.50%0.32 | -78.85%0.33 | -78.23%0.27 | -69.84%0.19 | -30.80%1.73 | -35.00%1.56 | -20.00%1.24 | 23.53%0.63 | 89.39%2.5 |
| Other composite income | -293.51%-512.04K | -14.04%2.18M | -130.98%-1.48M | -84.14%933.93K | 113.48%264.6K | -68.19%2.53M | -57.54%4.79M | 19.75%5.89M | -451.60%-1.96M | 520.29%7.96M |
| Other composite income of parent company owners | -293.51%-512.04K | -14.04%2.18M | -130.98%-1.48M | -84.14%933.93K | 113.48%264.6K | -68.19%2.53M | -57.54%4.79M | 19.75%5.89M | ---1.96M | --7.96M |
| Total composite income | 175.82%46.91M | -76.84%40.79M | -74.96%37.81M | -71.96%33.03M | -56.06%17.01M | 3.95%176.11M | -9.27%151M | 12.42%117.78M | 17.81%38.7M | 104.96%169.41M |
| Total composite income of parent company owners | 175.82%46.91M | -76.84%40.79M | -74.96%37.81M | -71.96%33.03M | -56.06%17.01M | 3.95%176.11M | -9.27%151M | 12.42%117.78M | --38.7M | --169.41M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.